Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4. Read more about Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4.
Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Read more about Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study.
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Read more about Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.
A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations. Read more about A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations.
Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis. Read more about Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis.
Evidence based consensus guidelines for diagnosis and management of Protoporphyria-Related liver dysfunction in erythropoietic protoporphyria and X-Linked protoporphyria. Read more about Evidence based consensus guidelines for diagnosis and management of Protoporphyria-Related liver dysfunction in erythropoietic protoporphyria and X-Linked protoporphyria.
Refining the approach to down-staging for hepatocellular carcinoma prior to liver transplantation: Patient selection, local-regional treatments, and systemic therapies. Read more about Refining the approach to down-staging for hepatocellular carcinoma prior to liver transplantation: Patient selection, local-regional treatments, and systemic therapies.
Use of HBV RNA and to predict change in serological status and disease activity in CHB. Read more about Use of HBV RNA and to predict change in serological status and disease activity in CHB.
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy. Read more about Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy.
Introducing Norah Terrault, MD, MPH, Our 2023 AASLD President. Read more about Introducing Norah Terrault, MD, MPH, Our 2023 AASLD President.
